Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)

Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)

The coronavirus SARS-CoV-2 is cause of a global pandemic of a pneumonia-like disease termed Coronavirus Disease 2019 (COVID-19). COVID-19 presents a high mortality rate, estimated at 3.4%. More than 1 out of 4 hospitalized COVID-19 patients require admission to an Intensive Care Unit (ICU) for respi...

Full description

Bibliographic Details
Main Authors: G. Lanzoni, E. Linetsky, D. Correa, R. Alvarez, A. Marttos, K. Hirani, S. Messinger Cayetano, J. Castro, M. Paidas, J. Efantis Potter, X. Xu, M. Glassberg, J. Tan, A. Patel, G. Goldstein, N. Kenyon, D. Baidal, R. Alejandro, R. Vianna, P. Ruiz, A. Caplan, C. Ricordi
Format: Article
Language:English
Published: Verduci Editore 2020-04-01
Series:CellR4
Subjects:
umbilical cord-derived mesenchymal stem cells (uc-mscs)
coronavirus disease 2019 (covid-19)
acute respiratory distress syndrome (ards)
Online Access:https://www.cellr4.org/wp-content/uploads/sites/2/2020/04/e2839-Umbilical-Cord-derived-Mesenchymal-Stem-Cells-for-COVID-19-Patients-with-Acute-Respiratory-Distress-Syndrome-ARDS.pdf

Internet

https://www.cellr4.org/wp-content/uploads/sites/2/2020/04/e2839-Umbilical-Cord-derived-Mesenchymal-Stem-Cells-for-COVID-19-Patients-with-Acute-Respiratory-Distress-Syndrome-ARDS.pdf

Similar Items